Germany
Japan
United Kingdom
China
ST2 mouse monoclonal antibody, clone OTI1D6
Research Areas
Download
ST2 mouse monoclonal antibody, clone OTI4F4
ST2 mouse monoclonal antibody, clone OTI4F4
ST2 mouse monoclonal antibody, clone OTI7E9
ST2 mouse monoclonal antibody, clone OTI7E9
ST2 mouse monoclonal antibody, clone OTI9H9
ST2 mouse monoclonal antibody, clone OTI9H9
ST2 mouse monoclonal antibody, clone OTI6C1
ST2 mouse monoclonal antibody, clone OTI6C1
TLR8 mouse monoclonal antibody,clone OTI2F5
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CD79B mouse monoclonal antibody,clone OTI3E3
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CD79B mouse monoclonal antibody,clone OTI7F8
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CD79B mouse monoclonal antibody,clone OTI2H8
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
MME mouse monoclonal antibody,clone OTI2A3
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
MME mouse monoclonal antibody,clone OTI2A4
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
CSF3 mouse monoclonal antibody,clone OTI4F11
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CSF3 mouse monoclonal antibody,clone OTI1E1
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
IL2 mouse monoclonal antibody,clone OTI2C9
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
MME mouse monoclonal antibody,clone OTI1E4
| Applications | FC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
CSF3 mouse monoclonal antibody,clone OTI1A9
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CSF3 mouse monoclonal antibody,clone OTI3F12
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
CSF3 mouse monoclonal antibody,clone OTI1G6
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CSF3 mouse monoclonal antibody,clone OTI3C10
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
IL2 mouse monoclonal antibody,clone OTI5A9
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
CSF3 mouse monoclonal antibody,clone OTI3A3
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CSF3 mouse monoclonal antibody,clone OTI1C7
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Clonalities
- Monoclonal
Conjugates
- Unconjugated
Filter by
Target Symbol
- IL6 (119)
- IL1RL1 (102)
- CD4 (85)
- PECAM1 (73)
- PDCD1 (70)
- PTPRC (58)
- CD99 (57)
- LGALS3 (54)
- CD68 (50)
- CD5 (48)
- CD19 (43)
- NCAM1 (43)
- CD274 (42)
- KIT (42)
- MS4A1 (42)
- TNFRSF8 (39)
- CD34 (30)
- CD2 (27)
- CR2 (27)
- MME (27)
- WNT3 (27)
- ESR1 (25)
- FCER2 (25)
- CD22 (23)
- CD33 (23)
- DVL2 (22)
- IL1RN (22)
- CRP (21)
- IL2RA (20)
- TNF (20)
- ANAPC11 (19)
- IL3RA (19)
- ROR2 (19)
- TYRO3 (19)
- ANAPC2 (18)
- CD14 (18)
- CD79B (18)
- MAPK8 (18)
- CSF3 (17)
- MAPK9 (16)
- CD3E (15)
- ANPEP (14)
- CD8A (14)
- CD74 (12)
- FCGR1A (12)
- MAPK10 (9)
- POSTN (9)
- PTK7 (9)
- RORA (9)
- IL2 (8)
- IL6R (8)
- ITGA2B (8)
- ITGB3 (8)
- AGTPBP1 (7)
- CD7 (7)
- CD79A (7)
- CD1A (6)
- IL1A (6)
- IL36G (6)
- ROR1 (6)
- CALR (5)
- IL12B (5)
- IL18 (5)
- TLR8 (5)
- TOLLIP (5)
- ESR2 (4)
- FCGR3A (4)
- HLA-A (4)
- IL1B (4)
- IL36A (4)
- CRYGD (3)
- HLA-DRB5 (3)
- IL10 (3)
- ITGAX (3)
- LEF1 (3)
- WNT3A (3)
- CXCL8 (2)
- FUT4 (2)
- HLA CLASS II (2)
- HLA-DQA2 (2)
- IL6RA (2)
- TLR2 (2)
- TLR3 (2)
- TMED1 (2)
- WNT5B (2)
- ANAPC5 (1)
- ARAF (1)
- BRAF (1)
- CASP1 (1)
- CD10 (1)
- CD207 (1)
- CD30 (1)
- CD3D (1)
- CD3G (1)
- CDC42SE2 (1)
- CKMT2 (1)
- ELK3 (1)
- IL1R2 (1)
- IRS1 (1)
- MAP2K2 (1)
Reactivities
Applications
Antibody Hosts
Isotypes
Carrier-free
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (11)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (6)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
Assay Types
Families
- Druggable Genome (1479)
- Transmembrane (1147)
- ES Cell Differentiation/IPS (486)
- Secreted Protein (455)
- Adult stem cells (175)
- Protein Kinase (150)
- Embryonic stem cells (86)
- Stem cell - Pluripotency (75)
- Induced pluripotent stem cells (73)
- Transcription Factors (57)
- Phosphatase (56)
- Protease (43)
- Nuclear Hormone Receptor (36)
- Cancer stem cells (31)
- Stem cell relevant signaling - Wnt Signaling pathway (4)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Hematopoietic cell lineage (652)
- Cell adhesion molecules (CAMs) (494)
- Cytokine-cytokine receptor interaction (272)
- Pathways in cancer (261)
- T cell receptor signaling pathway (254)
- Toll-like receptor signaling pathway (217)
- Primary immunodeficiency (188)
- NOD-like receptor signaling pathway (176)
- Jak-STAT signaling pathway (175)
- Prion diseases (167)
- Graft-versus-host disease (151)
- Hypertrophic cardiomyopathy (HCM) (135)
- Leukocyte transendothelial migration (131)
- Cytosolic DNA-sensing pathway (122)
- B cell receptor signaling pathway (109)
- Antigen processing and presentation (100)
- Melanogenesis (98)
- Wnt signaling pathway (98)
- MAPK signaling pathway (87)
- Progesterone-mediated oocyte maturation (83)
- Fc gamma R-mediated phagocytosis (71)
- Colorectal cancer (67)
- RIG-I-like receptor signaling pathway (61)
- Basal cell carcinoma (56)
- Endocytosis (56)
- Fc epsilon RI signaling pathway (56)
- Adipocytokine signaling pathway (54)
- Focal adhesion (54)
- Type II diabetes mellitus (54)
- Acute myeloid leukemia (49)
- ErbB signaling pathway (49)
- Lysosome (49)
- Neurotrophin signaling pathway (47)
- Insulin signaling pathway (46)
- Epithelial cell signaling in Helicobacter pylori infection (45)
- GnRH signaling pathway (44)
- Pancreatic cancer (44)
- Type I diabetes mellitus (40)
- Oocyte meiosis (39)
- Cell cycle (38)
- Ubiquitin mediated proteolysis (38)
- Alzheimer's disease (37)
- Apoptosis (35)
- Renin-angiotensin system (35)
- Regulation of actin cytoskeleton (34)
- Hedgehog signaling pathway (32)
- Allograft rejection (31)
- Systemic lupus erythematosus (30)
- Complement and coagulation cascades (26)
- Natural killer cell mediated cytotoxicity (22)
- Pathogenic Escherichia coli infection (22)
- Notch signaling pathway (21)
- Dilated cardiomyopathy (19)
- Asthma (17)
- Autoimmune thyroid disease (15)
- Metabolic pathways (14)
- Amyotrophic lateral sclerosis (ALS) (13)
- Glutathione metabolism (13)
- TGF-beta signaling pathway (12)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (11)
- Viral myocarditis (9)
- Chemokine signaling pathway (8)
- ECM-receptor interaction (7)
- Endometrial cancer (7)
- Prostate cancer (7)
- Adherens junction (6)
- Bladder cancer (5)
- Chronic myeloid leukemia (5)
- Glioma (5)
- Renal cell carcinoma (5)
- Thyroid cancer (5)
- VEGF signaling pathway (5)
- Vascular smooth muscle contraction (5)
- Long-term potentiation (4)
- Melanoma (4)
- Non-small cell lung cancer (4)
- mTOR signaling pathway (4)
- Axon guidance (3)
- Long-term depression (3)
- Tight junction (3)
- Gap junction (2)
- Small cell lung cancer (2)
- Arginine and proline metabolism (1)
- Inositol phosphate metabolism (1)
- Phosphatidylinositol signaling system (1)
- Vibrio cholerae infection (1)